During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is ...

An worker inspects the Nicotiana benthamiana plants at Medicago greenhouse in Quebec City (Reuters) - Canadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by ...

(RTTNews) - Medicago and GlaxoSmithKline (GSK.L, GSK) reported positive efficacy and safety results from the phase 3 placebo-controlled efficacy study of the plant-based COVID-19 vaccine candidate in ...

RALEIGH (WTVD) -- Sometimes things come full circle. Forty years ago, North Carolina's economy was based primarily on tobacco. And now a company with an RTP-based U.S. headquarters and a Raleigh-based ...

Medicago said on Tuesday it has begun testing its plant-based coronavirus vaccine in an early-stage clinical trial as the Canadian company, backed by tobacco company Phillip Morris, races against ...

QUEBEC CITY & LONDON--(BUSINESS WIRE)--Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announce positive efficacy and safety results from the global ...

Pharmaceutical companies Medicago and GlaxoSmithKline announced Tuesday “positive efficacy and safety results” from a global trial using what they say is the world’s first plant-based coronavirus ...

A Canadian drugmaker said its plant-based COVID-19 vaccine showed strong protection against the virus and will soon seek authorization at home and elsewhere. Medicago announced Tuesday that its ...

Medicago and GlaxoSmithKline have presented interim phase 2 data on their adjuvanted COVID-19 vaccine candidate. The results suggest the plant-derived jab CoVLP+AS03 is somewhat differentiated from ...

QUEBEC CITY--(BUSINESS WIRE)--Medicago, a biopharmaceutical company headquartered in Quebec City, is pleased to announce submission of the positive Phase 3 data for regulatory review by Health Canada ...